Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Healing of Foot Ulcers in Type 2 Diabetes
NCT07581145Phase 3Recruiting
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in diabetic foot ulcer (DFU). Started Apr 2026; status: recruiting.
02
Drugs
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07581145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581145.